VTRS Q1 2018 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.7B-1.3% YoY

Gross Profit

$984M36.7% margin

Operating Income

$156M5.8% margin

Net Income

$87M3.2% margin

EPS (Diluted)

$0.17

QoQ Revenue Growth

-17.1%

Cash Flow

Operating Cash Flow

$622M

Free Cash Flow

$591M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$35.2B

Total Liabilities

$22.0B

Stockholders' Equity

$13.2B

Cash & Equivalents

$367M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.7B	$2.7B	-1.3%
Gross Profit	$984M	$1.1B	-9.3%
Operating Income	$156M	$228M	-31.6%
Net Income	$87M	$66M	+31.2%